Cargando…
Antipsychotics and COVID-19: the debate goes on – Authors' reply
Autores principales: | De Picker, Livia, Mazza, Mario Gennaro, Vai, Benedetta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601685/ https://www.ncbi.nlm.nih.gov/pubmed/34801117 http://dx.doi.org/10.1016/S2215-0366(21)00428-4 |
Ejemplares similares
-
Antipsychotics and COVID-19: the debate goes on
por: Boland, Xavier, et al.
Publicado: (2021) -
Does antipsychotic use mediate the effect of psychiatric disorders on COVID-19? – Authors' reply
por: Yang, Huazhen, et al.
Publicado: (2021) -
Cancer and COVID-19 – Authors' reply
por: Kuderer, Nicole M, et al.
Publicado: (2020) -
Remdesivir and COVID-19 – Authors' reply
por: Wang, Yeming, et al.
Publicado: (2020) -
Comment on: “Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence”
por: Mazza, Mario Gennaro, et al.
Publicado: (2022)